Skip to content

Opioids

DOJ’s False Claims Act Civil Case Settlements and Judgments Exceed $5.6 Billion in Fiscal Year 2021 (Over $5 Billion Attributable to the Health Care Industry)

The Department of Justice announced that it obtained more than $5.6 billion in settlements and judgments from civil cases involving fraud and false claims against the government in the fiscal year ending September 30, 2021. This is the largest annual total in False Claims Act history, and the largest since 2014. The DOJ’s Fraud Statistics Overview can be found HERE. Once again, the leading source of the DOJ’s FCA settlements and judgments was attributable to matters involving the health care industry – over $5 billion… Read More »DOJ’s False Claims Act Civil Case Settlements and Judgments Exceed $5.6 Billion in Fiscal Year 2021 (Over $5 Billion Attributable to the Health Care Industry)

Justice Department Seeks Permanent Injunction Against San Antonio-Area Pharmacist for Controlled Substances Act Violations

On January 21, the DOJ announced it had filed a civil complaint seeking to permanently enjoin the owner of a San Antonio-area pharmacy from unlawfully dispensing opioids and other controlled substances. A copy of the Complaint can be found HERE. A copy of the Motion for Preliminary Injunction can be found below. The United States has alleged that Defendants fueled and profited from the opioid epidemic by repeatedly dispensing powerful opioids prone to abuse in violation of the Controlled Substances Act (“CSA”). According to the… Read More »Justice Department Seeks Permanent Injunction Against San Antonio-Area Pharmacist for Controlled Substances Act Violations

U.S. Attorney’s Office Files Suit Against Philadelphia Pharmacy and Pharmacist for Illegally Dispensing Opioids and Health Care Fraud

On January 27, 2022, the DOJ announced that the United States filed a civil lawsuit against a Philadelphia-based pharmacy and pharmacist. The Complaint can be found below. The United States alleges that this civil lawsuit was brought to hold the pharmacy and its then-owner/pharmacist accountable for the illegal dispensing of controlled substances, including opioids, and fraud on Medicare and other federal health care programs. According to the Complaint, the pharmacy is alleged to have been the top retail pharmacy purchaser of oxycodone in the entire… Read More »U.S. Attorney’s Office Files Suit Against Philadelphia Pharmacy and Pharmacist for Illegally Dispensing Opioids and Health Care Fraud